Warren Hosseinion

Dr. Warren Hosseinion, MD, is an Independent Director at General Purpose Acquisition Corp., a Chairman at Voyager Acquisition Corp.
II, a Non-Executive Chairman at Cardio Diagnostics Holdings, Inc., a President & Director at Nutex Health, Inc., a Chief Executive Officer at Clinigence Holdings, Inc. /Ga/ and an Independent Director at VERAXA Biotech AG.
He is on the Board of Directors at General Purpose Acquisition Corp., Nutex Health, Inc., Picard Medical Holdings, Inc. and VERAXA Biotech AG.
Dr. Hosseinion was previously employed as a Chairman by Voyager Acquisition Corp., a Chairman by Altitude Acquisition Corp., a Chairman by Cardio Diagnostics, Inc., a Chairman & Chief Executive Officer by Clinigence Holdings, Inc., a Chairman by Clinigence Holdings, Inc. /Old/, a Co-Chief Executive Officer, Secretary & Director by Apollo Medical Holdings, Inc., a Chief Executive Officer by Apollo Medical Management, Inc., a Co-Founder by ApolloMed Hospitalists Corp., a Chairman & Chief Executive Officer by Accountable Healthcare America, Inc., and a Chief Executive & Accounting Officer by Siclone Industries, Inc. He received his undergraduate degree from the University of San Francisco, a graduate degree from Georgetown University Graduate School of Arts & Sciences and a doctorate degree from Georgetown University School of Medicine.